Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Laguna Colorado
Often not enough for serious cases
That is the most substantial human outcome data currently available for a compound that people are sourcing and injecting based on internet research.[4,5] BPC-157 has been used in Phase II trials for ulcerative colitis and multiple sclerosis.[1,2] Comprehensive published results from those trials are not available in the medical literature
Trials conducted between 2001 and 2007 demonstrated statistically significant reductions in body fat, although the larger Phase IIb OPTIONS trial did not replicate these findings at sufficient magnitude for regulatory approval, and formal development was discontinued in 2007
US$ 28.86
US$ 29.52
US$ 22.88
